Shanghai United Cell Biotech

Shanghai United Cell Biotech is a prominent Chinese biopharmaceutical company specializing in the development, manufacture, and commercialization of vaccines and recombinant protein therapeutics. Established in 1995 as a subsidiary of United Biomedical, Inc. (UBI), the company operates a large-scale GMP-certified manufacturing facility in the Shanghai Waigaoqiao Free Trade Zone. Its flagship product is the rBS/WC oral cholera vaccine, which was the first of its kind to be approved and manufactured in China. The company also produces recombinant human growth hormone (rhGH) for the treatment of growth disorders in children and adults. Shanghai United Cell Biotech serves as a critical hub for the UBI group's manufacturing and commercial operations within the Asian market, focusing on infectious diseases and endocrinology.